ZEALAND PHARMA A/S
LIVE

Serial Number

86842067

Owner

ZEALAND PHARMA A/S

Attorney

Miriam D. Trudell

Filing Date

Dec 8, 2015

Add to watchlist:

No watchlists yet
View on USPTO

ZEALAND PHARMA A/S Trademark

Serial Number: 86842067 • Registration: 5597662

ZEALAND PHARMA A/S is a trademark filed by ZEALAND PHARMA A/S on December 8, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ZEALAND PHARMA A/S (41 trademarks)

SØBORG 2860 , DK

Entity Type: 03

Trademark Details

Filing Date

December 8, 2015

Registration Date

October 30, 2018

Goods & Services

(Based on Section 44(e)) Pharmaceutical preparations for the treatment of diseases, illnesses and ailments in humans and animals, namely, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment of diseases, illnesses and ailments in humans and animals, namely, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders; first aid kits; diagnostic kits comprised of pharmaceutical and chemical preparations for the treatment of diseases, illnesses, and ailments in humans and animals, namely, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders

[(Based on Section 44(e)) Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; peptide substrates used in analyzing and detecting certain toxins for laboratory or research use]

[(Based on Section 44(e)) Medical services; veterinary services; hygienic and beauty care for human beings or animals; horticulture services; dentistry services; medical analysis of peptide based medicines for the diagnosis and treatment of persons; pharmaceutical advice; medical consulting services in the field of diseases, illnesses and ailments in humans and animals, namely, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders]

[(Based on Section 44(e)) Scientific and technological services and research and design relating thereto in the field of medicine, pharmaceuticals, genetics, biology and biotechnology, namely, research, design of peptides and pharmaceutical drugs, medical and scientific laboratory services, scientific and medical research consulting services, and medical research, analysis and testing in the field of diseases, illnesses and ailments in humans and animals for scientific and research purposes, namely, in the fields of endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, and skin disorders; industrial analysis and research services in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; design and development of computer hardware and software; medical, biological, biotechnological, genetic, laboratory and pharmaceutical research, design and development services, namely, the development of medicines for the treatment of diseases, illnesses and ailments in humans and animals, namely, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders; laboratory research in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; information and consultancy services relating to all the aforesaid, namely, information and consultancy services relating to the development of medicines for the treatment of diseases, illnesses and ailments in humans and animals, namely, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders]

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 28, 2025 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Aug 28, 2025 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 28, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 28, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 28, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 28, 2025 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Jul 28, 2025 NAS8
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Jul 28, 2025 8.PR
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 21, 2025 APRE
TEAS SECTION 8 RECEIVED
Oct 22, 2024 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 30, 2023 REM1
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jun 23, 2022 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Feb 4, 2022 ASCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 23, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 23, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 23, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 23, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 23, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 23, 2021 COAR
REGISTERED-SUPPLEMENTAL REGISTER
Oct 30, 2018 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 25, 2018 PREV
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Sep 25, 2018 CNTA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 24, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 24, 2018 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
May 29, 2018 GNS1
SUBSEQUENT FINAL EMAILED
May 29, 2018 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
May 29, 2018 CFRC
ASSIGNED TO EXAMINER
May 8, 2018 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 6, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 5, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 5, 2018 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Nov 21, 2017 GPRN
PRIORITY ACTION E-MAILED
Nov 21, 2017 GPRA
PRIORITY ACTION WRITTEN
Nov 21, 2017 CPRA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 27, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 27, 2017 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 23, 2017 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 28, 2017 GNFN
FINAL REFUSAL E-MAILED
Apr 28, 2017 GNFR
FINAL REFUSAL WRITTEN
Apr 28, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 6, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 6, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 6, 2017 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 25, 2017 CHAN
ASSIGNED TO LIE
Jan 23, 2017 ALIE
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 29, 2016 EWAF
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 7, 2016 GNRN
NON-FINAL ACTION E-MAILED
Oct 7, 2016 GNRT
NON-FINAL ACTION WRITTEN
Oct 7, 2016 CNRT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 16, 2016 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 16, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 16, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 16, 2016 TROA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sep 16, 2016 EWAF
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 30, 2016 GNRN
NON-FINAL ACTION E-MAILED
Mar 30, 2016 GNRT
NON-FINAL ACTION WRITTEN
Mar 30, 2016 CNRT
ASSIGNED TO EXAMINER
Mar 25, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 11, 2015 NWOS
NEW APPLICATION ENTERED
Dec 11, 2015 NWAP